Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Share-based Compensation (2018 - 2021)

Acro Biomedical has reported Share-based Compensation over the past 3 years, most recently at $3.9 million for Q4 2021.

  • Quarterly results put Share-based Compensation at $3.9 million for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $6.8 million (up 2206.94% YoY), and the annual figure for FY2021 was $7.7 million, changed.
  • Share-based Compensation for Q4 2021 was $3.9 million at Acro Biomedical, up from $2.9 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ACBM hit a ceiling of $3.9 million in Q4 2021 and a floor of $148395.0 in Q1 2019.
  • Median Share-based Compensation over the past 3 years was $150044.5 (2018), compared with a mean of $1.2 million.